Skip to main content
Log in

Blood glucose self monitoring not economical in T2DM

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A, Diabetes Glycaemic Eduction and Monitoring Trial Group.Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 336: 1177-1180, No. 7654, 24 May 2008

  2. O'Kane MJ, Bunting B, Copeland M, Coates VE, ESMON Study Group.Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 336: 1174-1177, No. 7654, 24 May 2008

  3. Gulliford M.Self monitoring of blood glucose in type 2 diabetes. BMJ 336: 1139-1140, No. 7654, 24 May 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blood glucose self monitoring not economical in T2DM. Pharmacoecon. Outcomes News 553, 6 (2008). https://doi.org/10.2165/00151234-200805530-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805530-00009

Keywords

Navigation